" class="no-js "lang="en-US"> Samar Mahmoud - Medtech Alert
Monday, April 15, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Samar Mahmoud

Samar Mahmoud

About Samar Mahmoud

● Knowledgeable innovator and experienced data analyst as demonstrated by developing 2 pattern recognition methods to improve the interpretability of multi-source toxicological data

● Good communication skills with ability to manage research projects resulting in publications and cross-functional collaborations with AstraZeneca, GSK and Lhasa

● Excellent background in pharmaceutical sciences and drug discovery resulting in several academic awards and research bursaries

● During free time, I enjoy practicing calligraphy art, hand lettering and crafts.
Happy to connect!

Related Story

Artificial Intelligence

 Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances | Pharmtech Focus

Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances

December 9 2021

Optibrium Limited, a leading provider of software and artificial intelligence (AI) solutions for drug discovery, […]